Cumberland announces study showing Caldolor reduces adverse drug reactions vs ketorolac

CUMBERLAND PHARMACEUTICALS INC

Study analyzed records of >17M patients; compared 31,046 Caldolor vs 124,184 ketorolac adults.
Caldolor associated with 45% reduction in renal dysfunction (p<0.001) and 78% fewer hematuria events.
In pediatric patients, Caldolor showed 51-65% lower rate of adverse drug reactions.
Caldolor also linked to decreased ER visits and shorter hospital stay for both adults and children.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.